The gene RPF1 (retina-derived POU domain factor 1) is mapped to human chromosome 7p14. The protein belongs to the POU-homeodomain transcription factors. RPF1 is commonly referred to as POU6F2 (POU domain, class 6, transcription factor 2).
Synonyms: Anti-BXDC5; Anti-Brix domain-containing protein 5; Anti-Ribosome biogenesis protein RPF1; Anti-Ribosome production factor 1
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: RPF1 (retina-derived POU domain factor 1, also referred to as POU6F2 (POU domain, class 6, transcription factor 2)) works as a tumor suppressor and is involved in Wilms tumor. POU6F2 might be involved in cell proliferation. Long non-coding RNA POU6F2-AS2 (POU6F2 antisense RNA 2) is linked with esophageal squamous cell carcinoma.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC